Companies: 10,795·Total market cap: $144.5T
Orexo AB (publ)

Orexo AB (publ)

ORXOFOTCHealthcare● Active
$2.90
+$0.80(+38.10%)
Market Cap$101866717
P/E Ratio
52W High$3.23
52W Low$1.08

Orexo AB (publ) (ORXOF) Revenue

Annual & quarterly revenue history · segment & region breakdown

ORXOF · revenue · updated Jun 9, 2026

Core revenue metrics

Orexo AB (publ) trailing twelve-month (TTM) revenue is $0.24B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.24B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
0.42×
mktCap ÷ TTM rev
Revenue per day
$1M
Est. TTM ÷ 365
Revenue / employee
$2222K
110 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Orexo AB (publ) SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
ORXOF revenue by year · ORXOF revenue history · ORXOF annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Orexo AB (publ) receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Orexo AB (publ) reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Orexo AB (publ)'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

ORXOF revenue · 4 questions

ORXOF's trailing twelve-month (TTM) revenue is $0.24B. That is an increase of 0.00% year-over-year from — in FY.

ORXOF revenueORXOF annual revenuewhat is ORXOF revenueORXOF TTM revenue

Source: FMP · Orexo AB (publ) SEC filings · GAAP · Orexo AB (publ) SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026